| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.46B | 25.20B | 27.63B | 15.69B | 25.63B | 37.17B |
| Gross Profit | 3.42B | 4.83B | 4.82B | 4.83B | 7.27B | 10.85B |
| EBITDA | 3.97B | 8.70B | 8.59B | 7.81B | 9.62B | 11.75B |
| Net Income | 1.12B | 1.61B | 1.69B | 1.41B | 3.92B | 6.09B |
Balance Sheet | ||||||
| Total Assets | 135.82B | 131.59B | 126.37B | 125.93B | 128.15B | 132.62B |
| Cash, Cash Equivalents and Short-Term Investments | 14.05B | 10.28B | 8.74B | 13.69B | 16.20B | 19.09B |
| Total Debt | 75.98B | 66.46B | 72.12B | 76.54B | 93.18B | 91.29B |
| Total Liabilities | 104.25B | 100.36B | 95.76B | 96.65B | 99.25B | 99.93B |
| Stockholders Equity | 31.12B | 30.79B | 30.30B | 29.28B | 28.89B | 32.69B |
Cash Flow | ||||||
| Free Cash Flow | -4.51B | -4.45B | -3.21B | -433.22M | 110.19M | -19.75B |
| Operating Cash Flow | 3.83B | 5.19B | 6.70B | 5.31B | 11.21B | 14.58B |
| Investing Cash Flow | -5.59B | -5.41B | -3.11B | 962.73M | -300.66M | -15.21B |
| Financing Cash Flow | 3.32B | 1.72B | -8.29B | -8.93B | -14.49B | 5.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$94.90B | 4.00 | 48.55% | 9.80% | 11.50% | 17.54% | |
71 Outperform | HK$95.75B | 4.75 | 11.33% | 12.81% | -9.21% | -41.30% | |
65 Neutral | HK$251.57B | 8.62 | 10.75% | 12.48% | -6.12% | -35.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$17.01B | 11.88 | 2.51% | 2.88% | -19.46% | -55.11% | |
60 Neutral | HK$130.07B | 9.93 | 9.13% | 4.76% | 2.50% | -2.32% | |
46 Neutral | HK$32.64B | 7.91 | 5.00% | 4.16% | -8.82% | 11.45% |